ArticleFrontiers in genetics2026
mwHIT: accelerated and accurate histone modification imputation using multi-scale window attention.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Histone modifications regulate chromatin organization and gene activity, and abnormal modification patterns are closely associated with disease-related transcriptional dysregulation. Although ChIP-seq provides accurate measurements of histone modification profiles, genome-wide experimental profiling remains costly and time-consuming. Here, we propose mwHIT, a multi-scale window attention-based Histone Modification Imputation Transformer that predicts histone modification signals from run-on sequencing (RO-seq) and DNA sequence features. mwHIT captures both local and long-range regulatory information while reducing the computational cost of transformer-based inference. Across cell lines and histone marks, mwHIT achieved an average Pearson correlation of 0.7086 in matched method comparisons, outperforming dHIT and Enformer by 13.7% and 33.4%, respectively. On the GM12878 benchmark, mwHIT reduced average mean squared error (MSE) by 69.7% relative to dHIT and 34.6% relative to Enformer. Compared with a full-attention transformer baseline, the multi-scale window attention design reduced runtime from 0.05 h to 0.03 h while maintaining comparable or slightly higher predictive accuracy. mwHIT also recovered histone modification patterns in promoters, enhancers, gene bodies, and regions centered on transcription start sites (TSSs), and highlighted disease-associated regulatory signals near the IL2RA locus. These results demonstrate that mwHIT can support the discovery of disease-associated regulatory markers and provide computational evidence for prioritizing candidate regulatory regions and potential regulatory targets. mwHIT's data processing methods and model code are freely available in the mwHIT GitHub repository at https://github.com/zhichunlizzx/mwHIT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.